SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
10 nov. 2023 09h10 HE
|
SciSparc Ltd
SciSparc to conduct trial at Yale University in the USA, Tel Aviv Sourasky Medical Center in Israel and the Hannover Medical School in Germany TEL AVIV, Israel, Nov. 10, 2023 (GLOBE NEWSWIRE) --...
Germany’s BfArM Joins SNOMED International for Nationwide Use of SNOMED CT
06 janv. 2021 08h00 HE
|
SNOMED International
LONDON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has announced their membership in SNOMED International for national use of SNOMED CT from...